MedTrace Logo

A Safety and Efficacy Evaluation of BLI801 Laxative in Constipated Adults

NCT01687985 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 81

Last updated 2014-07-16

No results posted yet for this study

Summary

A pilot study to evaluate the safety and efficacy of multiple BLI801 doses in constipated adults.

Conditions

Interventions

DRUG

BLI801 laxative - low dose

BLI801 laxative - oral solution

DRUG

BLI801 laxative - high dose

BLI801 laxative - oral solution

Sponsors & Collaborators

  • Braintree Laboratories

    lead INDUSTRY

Principal Investigators

  • John McGowan, MPH · Braintree Laboratories, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2013-03-31
Completion
2013-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01687985 on ClinicalTrials.gov